Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: A systematic review and meta-analysis

Obesity Surgery

Volumn 24, Issue 3, 2014, Pages 437-455

  Ribaric, G ^a   Buchwald, J N ^b   McGlennon, T W ^c  

^a ETHICON INC   (United States)

^b Division of Scientific Writing   (United States)

^c McGlennon MotiMetrics   (United States)

Author keywords

Bariatric; Comparative; Meta analysis; Metabolic; Randomized controlled trial; Systematic review; T2DM; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CALORIC INTAKE; COMPARATIVE EFFECTIVENESS; CONVENTIONAL MEDICAL THERAPY; DIET RESTRICTION; FASTING PLASMA GLUCOSE; FOLLOW UP; GASTRIC BANDING; GASTROPLASTY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; ROUX EN Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; STOMACH BYPASS; SYSTEMATIC REVIEW; THERAPY; WEIGHT REDUCTION;

BARIATRIC SURGERY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; WEIGHT LOSS;

EID: 84898040776     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1160-3     Document Type: Review

References (87)

1. Sims EH et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457-96.
2. World Health Organization. Obesity and overweightfact sheet No. 311. Updated March 2013. Accessed June 11, 2013: http://www. who.int/mediacentre/ factsheets/fs311/en/index.html
3. World Health Organization. Obesity and overweightfact sheet no. 312. Updated March 2013. http://www.who.int/mediacentre/ factsheets/fs312/en/. Accessed 11 June 2013
4. Andersson C, van Gaal L, Caterson ID, et al. Relationship between HbA1C levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia. 2012;55(9):2348-55.
5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. (Pubitemid 39346675)
6. The Surgeon General's call to action to prevent and decrease overweight and obesity/ Office of Disease Prevention and Health Promotion; Centers for Disease Control and Prevention, National Institutes of Health. [Rockville, MD]: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; Washington, D.C., 2001.
7. Resnick HE, Foster GL, Beardsley J, et al. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care. 2006;29:531-7. (Pubitemid 44115349)
8. Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 MONO): randomized, 52-week, phase III, double blind, parallel-treatment trial. Lancet. 2009;373:473-81.
9. Wong K, Glovaci D, Malik S, et al. Comparison of demographic factors and cardiovascular risk factor control among US adults with type 2 diabetes by insulin treatment classification. J Diabetes Complicat. 2012;26(3):169-74.
10. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) triala prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219-34.
11. Nguyen N, Champion JK, Ponce J, et al. A review of unmet needs in obesity management. Obes Surg. 2012;22(6):956-66.
12. Christiansen T, Brunn JM, Madsen EL, et al. Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity. 2007;15(2):413-20. (Pubitemid 46407323)
13. Goodrick GK, Foreyt JP. Why treatments for obesity don't last. JAMA. 1991;91:1243-7.
14. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-50.
15. Fried M, Ribaric G, Buchwald JN. Metabolic surgery for the treatment of type 2 diabetes in patients <35 kg/m2: an integrative review of early studies. Obes Surg. 2012;20(6):776-90.
16. Scopinaro N, Papadia F, Marinari G, et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg. 2007;17:185-92. (Pubitemid 47091579)
17. Ritter S, Vetter ML, Sarwer DB. Lifestyle modifications and surgical options in the treatment of patients with obesity and type 2 diabetes mellitus. Postgrad Med. 2012;124(4):168-80.
18. Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis. 2012;8(1):20-4.
19. Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479-85. (Pubitemid 352008510)
20. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
21. Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet. 2012;379:2300-11.
22. Buchwald H, Estok R, Fahrbach K, et al.Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3): 248-56-e5.
23. Spann SJ, Nutting PA, Galliher JM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med. 2006;4:23-31. (Pubitemid 43243909)
24. American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;33 Suppl 1:S11-61.
25. le Roux CW, Welbourn R, Werling M. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780-5. (Pubitemid 350035654)
26. Cummings DE, Overduin J, Foster-Schubert K-E. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608-15. (Pubitemid 38766339)
27. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab. 2003;88:2999-3002. (Pubitemid 36877461)
28. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-9. (Pubitemid 44629948)
29. Pories WJ, Caro JF, Flickinger EG, et al. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville gastric bypass. Ann Surg. 1987;206:316-23. (Pubitemid 17159705)
30. Guidone C,MancoM, Valera-Mora E, et al.Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025-31. (Pubitemid 44509976)
31. MacDonald KG, Long SD, Swanson MS. The gastric bypass operation reduces the progression and mortality of noninsulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213-20. (Pubitemid 127432762)
32. Cummings DE, Overduin J, ShannonMH. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg Obes Relat Dis. 2005;1:358-68.
33. Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98(7):2765-73.
34. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/ index.aspx?o=5653. Accessed 30 March 2013.
35. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med. 2009;6(6):e1000097.
36. North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication #00-4084, October 2000.
37. Duriak J. How to select, calculate, and interpret effect sizes. J Pediatr Psychol. 2009;34(9):917-28.
38. Furukawa TA, Barbui C, Cipriani A, et al. Imputingmissing standard deviation in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59:7-10. (Pubitemid 41797469)
39. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
40. Shikata S, Nakayama S, Yamagishi H. Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg. 2006;244(5):668-76. (Pubitemid 44629938)
41. Sjstrm L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93. (Pubitemid 39665322)
42. OBrien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. A randomized trial. Ann Intern Med. 2006;144: 625-33. (Pubitemid 46780646)
43. Dixon JB, OBrien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-23. (Pubitemid 351159368)
44. Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735-45.
45. Adams TD, Pendleton RC, Strong MB, et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring). 2010;18(1):121-30.
46. Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and bodymass index <35 kg/m2. Surgery. 2011;150(4):684-91.
47. Martins C, Strømmen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesitychanges in body weight, risk factors and comorbidities at 1 year. Obes Surg. 2011;21(7):84-9.
48. Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of biliopancreatic diversion on diabetic complications: a 10-year followup. Diabetes Care. 2011;34(3):561-7.
49. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011;253(4):699-703.
50. Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg. 2012;147(8):694-700.
51. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577-85.
52. Heo YS, Park JM, Kim YJ, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. J Korean Surg Soc. 2012;83(6):335-42.
53. Dorman RB, Serrot FJ, Miller CJ, et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg. 2012;255(2):287-93.
54. Leslie DB, Dorman RB, Serrot FJ, et al. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obes Surg. 2012;22(3):367-74.
55. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-76.
56. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial. JAMA. 2013;309(21):2240-9.
57. Buchwald H, Oien D. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427-36.
58. Shukla AP, Moreira M, Dakin G, et al. Medical versus surgical treatment of type 2 diabetes: the search for level 1 evidence. Surg Obes Relat Dis. 2012;8(4):476-82.
59. No authors listed. Gastrointestinal Surgery for Severe Obesity. Consen Statement 1991; 9(1):1-20.
60. Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31(4):569-77. (Pubitemid 46482359)
61. Shrier I, Boivin J-F, Steele RJ, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007;166:1203-9. (Pubitemid 350022749)
62. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142:56-66.
63. Dansinger ML, Tabsioni A,Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147(1): 41-50. (Pubitemid 351664633)
64. RittM, Piza H, RhombergM, et al.Metabolic risk factors in formerly obese womeneffects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone. Diabetes Obes Metab. 2005;7(3):216-22. (Pubitemid 40542811)
65. Anderson JW, Grant L, Gotthelf L, et al. Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program. Int J Obes. 2007;31(3):488-93.
66. Gill RS, Birch DW, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6: 707-13.
67. Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev 2009; CD003641.
68. Maggard-GibbonsM,MaglioneM, LivhitsM, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250-61.
69. Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized medical versus surgical treatment of type 2 diabetes: the search for level 1 evidence. Obes Rev. 2011;12:602-21.
70. Gregg EW, Chen H, Wagenknecht LE, et al. for the Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489-96.
71. Reed MA, Pories WJ, Chapman W, et al. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab. 2011;96(8):2525-31.
72. Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes, Obes Metab. 2012;14:262-70.
73. Turner RC, Mill NSH, Haw N, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study. BMJ. 1998;339:229-34.
74. Saydah S, Tao M, Imperatore G, et al. GHb level and subsequent mortality among adults in the US. Diabetes Care. 2009;32:1440-6.
75. Khow KT, Warham N, Bingham S, et al. Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. J Ann Intern Med. 2004;141:413-20.
76. Kenngott HG, Clemens G, Gondan M, et al. DiaSurg 2 trial surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a bodymass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial. Trials. 2013;14(1):183.
77. OBrien PE, Brennan L, Laurie C, et al. Intensivemedical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomized trial. Obes Surg. 2013;23:1345-53.
78. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9. (Pubitemid 36026281)
79. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-200. (Pubitemid 33015548)
80. North American Association for the Study of Obesity (NAASO) and the National Heart. Clinical Guide lines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda, MD: National Institutes of Health; 1998. NIH publication 98-4083.
81. Rubino F, Schauer PR, Kaplan LM, et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393-411.
82. Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatricmetabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365-72.
83. Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Phys India. 2009;57:163-70.
84. Razak F, Anand SS, ShannonH, et al. Defining ity points in a tiethnic population. Circulation. 2007;115:2111-8. (Pubitemid 46659062)
85. Dixon JB, Zimmet P, Alberti KG, et al. on behalf of the International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28:628-42.
86. Centers for Medicare and Medicaid Services. Decision Memo for Surgery for Diabetes (CAG-00397 N). http://www.cms.gov/ medicare-coverage-database/details/ nca-decision-memo.aspx? NCAId=219&NcaName=Surgery+for+Diabetes&NCDId= 326&ncdver=1&IsPopup=y&bc=AAAAAAAACAAAAA%3D% 3D&. Accessed on 10 July 2013.
87. Finkelstein EA, Øsbye T, Malhotra R. Bodymass trajectories through mid-life among adults with class-I obesity. Surg Obes Relat Dis. 2013;9:547-53.